Avantor, Inc. (NYSE:AVTR) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lowered its stake in shares of Avantor, Inc. (NYSE:AVTR) by 9.1% in the third quarter, HoldingsChannel reports. The fund owned 3,274,675 shares of the company’s stock after selling 329,558 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Avantor were worth $84,715,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Versant Capital Management Inc grew its position in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. lifted its stake in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares in the last quarter. UMB Bank n.a. purchased a new stake in shares of Avantor during the 3rd quarter worth about $49,000. Nisa Investment Advisors LLC increased its position in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after purchasing an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. 1.50% of the stock is currently owned by insiders.

Avantor Stock Performance

Shares of AVTR stock opened at $20.74 on Monday. The stock has a market capitalization of $14.12 billion, a price-to-earnings ratio of 45.09, a PEG ratio of 2.51 and a beta of 1.35. Avantor, Inc. has a one year low of $19.11 and a one year high of $28.00. The company’s 50-day simple moving average is $24.52 and its 200-day simple moving average is $24.00. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Wells Fargo & Company decreased their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. TD Cowen increased their price target on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Morgan Stanley increased their target price on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Barclays reduced their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.